For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250408:nRSH1839Ea&default-theme=true
RNS Number : 1839E Sabre Insurance Group PLC 08 April 2025
8 April 2025
Sabre Insurance Group plc ("Sabre" or the "Company")
Notification of transactions of Directors, Persons Discharging Managerial
Responsibility or Connected Persons
Awards under the Company's Deferred Bonus Plan
The Company announces that on 8 April 2025, the following directors and PDMRs
of the Company were, subject to the rules of the Sabre 2017 Deferred Bonus
Plan, each granted a conditional award (the 'DBP Award') of ordinary shares of
£0.001 in the Company, in respect of bonuses earned for the financial year
ended 31 December 2024 as detailed below:
Name Position Number of shares subject to award
Geoff Carter Chief Executive Officer 182,629
Anneka Kingan Chief Risk Officer and Company Secretary 75,630
Trevor Webb Claims Director 142,566
Adam Westwood Chief Financial Officer 95,879
Matthew Wright Chief Actuary 95,843
Subject to the rules of the Sabre 2017 Deferred Bonus Plan, the DBP Awards
will vest on the second anniversary of the grant date.
This notification is made pursuant to Article 19 of the EU Market Abuse
Regulation.
Additional Information:
Anneka Kingan - Company Secretary
Anneka.kingan@sabre.co.uk (mailto:Anneka.kingan@sabre.co.uk)
PDMR transaction notification
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Geoff Carter
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Sabre Insurance Group Plc
b) LEI 2138006RXRQ8P8VKGV98
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument A non-transferable conditional award of ordinary shares in the Company under
the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR
on the grant or vesting of the conditional award.
Identification code GB00BYWVDP49
b) Nature of the transaction Grant of conditional award
c) Price(s) and volume(s)
Price per share Volume
£1.294 182,629
d) Aggregated Information
Volume Price per share
Volume 182,629 £1.294
Price
e) Date of transaction 8 April 2025
f) Place of transaction London Stock Exchange (XLON)
d)
Aggregated Information
Volume
Price
Volume Price per share
182,629 £1.294
e)
Date of transaction
8 April 2025
f)
Place of transaction
London Stock Exchange (XLON)
PDMR transaction notification
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Anneka Kingan
2 Reason for the notification
a) Position/status Chief Risk Officer and Company Secretary
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Sabre Insurance Group Plc
b) LEI 2138006RXRQ8P8VKGV98
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument A non-transferable conditional award of ordinary shares in the Company under
the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR
on the grant or vesting of the conditional award.
Identification code GB00BYWVDP49
b) Nature of the transaction Grant of conditional award
c) Price(s) and volume(s)
Price per share Volume
£1.294 75,630
d) Aggregated Information
Volume Price per share
Volume 75,630 £1.294
Price
e) Date of transaction 8 April 2025
f) Place of transaction London Stock Exchange (XLON)
d)
Aggregated Information
Volume
Price
Volume Price per share
75,630 £1.294
e)
Date of transaction
8 April 2025
f)
Place of transaction
London Stock Exchange (XLON)
PDMR transaction notification
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Trevor Webb
2 Reason for the notification
a) Position/status Claims Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Sabre Insurance Group Plc
b) LEI 2138006RXRQ8P8VKGV98
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument A non-transferable conditional award of ordinary shares in the Company under
the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR
on the grant or vesting of the conditional award.
Identification code GB00BYWVDP49
b) Nature of the transaction Grant of conditional award
c) Price(s) and volume(s)
Price per share Volume
£1.294 142,566
d) Aggregated Information
Volume Price per share
Volume 142,566 £1.294
Price
e) Date of transaction 8 April 2025
f) Place of transaction London Stock Exchange (XLON)
d)
Aggregated Information
Volume
Price
Volume Price per share
142,566 £1.294
e)
Date of transaction
8 April 2025
f)
Place of transaction
London Stock Exchange (XLON)
PDMR transaction notification
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Adam Westwood
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Sabre Insurance Group Plc
b) LEI 2138006RXRQ8P8VKGV98
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument A non-transferable conditional award of ordinary shares in the Company under
the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR
on the grant or vesting of the conditional award.
Identification code GB00BYWVDP49
b) Nature of the transaction Grant of conditional award
c) Price(s) and volume(s)
Price per share Volume
£1.294 95,879
d) Aggregated Information
Volume Price per share
Volume 95,879 £1.294
Price
e) Date of transaction 8 April 2025
f) Place of transaction London Stock Exchange (XLON)
d)
Aggregated Information
Volume
Price
Volume Price per share
95,879 £1.294
e)
Date of transaction
8 April 2025
f)
Place of transaction
London Stock Exchange (XLON)
PDMR transaction notification
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Matthew Wright
2 Reason for the notification
a) Position/status Chief Actuary
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Sabre Insurance Group Plc
b) LEI 2138006RXRQ8P8VKGV98
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument A non-transferable conditional award of ordinary shares in the Company under
the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR
on the grant or vesting of the conditional award.
Identification code GB00BYWVDP49
b) Nature of the transaction Grant of conditional award
c) Price(s) and volume(s)
Price per share Volume
£1.294 95,843
d) Aggregated Information
Volume Price per share
Volume 95,843 £1.294
Price
e) Date of transaction 8 April 2025
f) Place of transaction London Stock Exchange (XLON)
d)
Aggregated Information
Volume
Price
Volume Price per share
95,843 £1.294
e)
Date of transaction
8 April 2025
f)
Place of transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHEVLFBEZLLBBV